Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2021
Working with the European Parliament
TRIPS Waiver: The Push Continues
Talking Medicine Pricing
Clinical Trial Data and the Risk of Bias
Getting Hack to Reality
C-TAP has not (yet) lived up to high expectations
A Pandemic Response Lacking Moral Leadership
Annual Report 2020 – A Year Like No Other
Challenging the IP Protection Framework
Health Action International at 40 – A Word from Executive Director, Tim Reed
2020
There is no UHC without Universal Medicines Coverage
Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic
What do the next five years have in store for the European Medicines Agency?
Dutch institutions failing to register results of clinical trials
COVID-19 risks turning back the clock on years of essential development work
Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya
Reflections on the World Health Assembly
COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa
EU Must Not Miss its Chance on WHO Technology Pool
TRIPS-flexibilities in Health Crises and Beyond
Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19
COVID-19, social determinants and frontline workers
Health Action International Working from Home
HAI Follows Dutch Government Advice in Response to COVID-19
2019